Berberine Ameliorates Chronic Kidney Injury Caused by Atherosclerotic Renovascular Disease through the Suppression of NFκB Signaling Pathway in Rats

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Wan, Xin ^a   Chen, Xin ^a   Liu, Lin ^b   Zhao, Ye ^a   Huang, Wen Juan ^b   Zhang, Qian ^a   Miao, Gang Gang ^a   Chen, Wen ^a   Xie, Hong Guang ^a,c   Cao, Chang Chun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BERBERINE; CHOLESTEROL; CREATININE; DNA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROTIC RENOVASCULAR DISEASE; CELL ULTRASTRUCTURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOPPLER ECHOGRAPHY; ENZYME ACTIVITY; HISTOLOGY; IN VIVO STUDY; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY INJURY; LIPID ANALYSIS; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DNA BINDING; RAT; RENAL PROTECTION; RENOVASCULAR DISEASE; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; BERBERINE; BIOLOGICAL MARKERS; FIBROSIS; INFLAMMATION; MALE; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; RENAL ARTERY OBSTRUCTION; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION; SYSTOLE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; ULTRASONOGRAPHY, DOPPLER;

RATTUS;

EID: 84875472574     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059794     Document Type: Article

References (35)

1. Keddis MT, Garovic VD, Bailey KR, Wood CM, Raissian Y, et al. (2010) Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates. Nephrol Dial Transplant 25: 3615-3622.
2. Urbieta-Caceres VH, Lavi R, Zhu XY, Crane JA, Textor SC, et al. (2010) Early atherosclerosis aggravates the effect of renal artery stenosis on the swine kidney. Am J Physiol Renal Physiol 299: F135-140.
3. Lerman LO, Textor SC, Grande JP, (2009) Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond. Prog Cardiovasc Dis 52: 196-203.
4. Schiffrin EL, Lipman ML, Mann JF, (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation 116: 85-97.
5. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, et al. (2006) Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55: 2256-2264.
6. Wang Y, Campbell T, Perry B, Beaurepaire C, Qin L, (2011) Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet and streptozotocin-induced diabetic rats. Metabolism 60: 298-305.
7. Kong W, Wei J, Abidi P, Lin M, Inaba S, et al. (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10: 1344-1351.
8. Jiang Q, Liu P, Wu X, Liu W, Shen X, et al. (2011) Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway. Mol Cell Endocrinol 331: 34-40.
9. Li N, Gu L, Qu L, Gong J, Li Q, et al. (2010) Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cells. Eur J Pharm Sci 40: 1-8.
10. Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, et al. (2002) Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 106: 1165-1171.
11. Lu M, Liu YH, Goh HS, Wang JJ, Yong QC, et al. (2010) Hydrogen sulfide inhibits plasma renin activity. J Am Soc Nephrol 21: 993-1002.
12. Chade AR, Rodriguez-Porcel M, Herrmann J, Zhu X, Grande JP, et al. (2004) Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol 15: 958-966.
13. Putta S, Lanting L, Sun G, Lawson G, Kato M, et al. (2012) Inhibiting micro-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol 23: 458-469.
14. Cao CC, Ding XQ, Ou ZL, Liu CF, Li P, et al. (2004) Small interfering RNA targeting IKKβ prevents renal ischemia-reperfusion injury in rats. Kidney Int 65: 834-845.
15. An WS, Kim HJ, Cho KH, Vaziri ND, (2009) Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am J Physiol Renal Physiol 2297: F895-903.
16. Jeong HW, Hsu KC, Lee JW, Ham M, Huh JY, et al. (2009) Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab 296: E955-964.
17. Wu N, Sarna LK, Siow YL, O K, (2011) Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia. Am J Physiol Regul Integr Comp Physiol 300: R635-643.
18. Lee TS, Pan CC, Peng CC, Kou YR, Chen CY, et al. (2010) Anti-atherogenic effect of berberine on LXRalpha-ABCA1-dependent cholesterol efflux in macrophages. J Cell Biochem 111: 104-110.
19. Agarwal D, Elks CM, Reed SD, Mariappan N, Majid DS, et al. (2012) Chronic Exercise Preserves Renal Structure and Hemodynamics in Spontaneously Hypertensive Rats. Antioxid Redox Signal 16: 139-152.
20. Ross R, (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
21. Vaziri ND, Rodriguez-Iturbe B, (2006) Mechanisms of disease: Oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2: 582-593.
22. Sarna LK, Wu N, Hwang SY, Siow YL, O K, (2010) Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophage. Can J Physiol Pharmacol 88: 369-378.
23. Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning RD Jr, (2005) Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 45: 934-939.
24. Elks CM, Reed SD, Mariappan N, Shukitt-Hale B, Joseph JA, et al. (2011) A Blueberry-Enriched Diet Attenuates Nephropathy in a Rat Model of Hypertension via Reduction in Oxidative Stress. PLoS One 6: e24028.
25. Chade AR, Herrmann J, Zhu X, Krier JD, Lerman A, et al. (2005) Effects of proteasome inhibition on the kidney in experimental hypercholesterolemia. J Am Soc Nephrol 16: 1005-1012.
26. Kronenberg F, (2009) Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol 5: 677-689.
27. Iacobini C, Menini S, Ricci C, Scipioni A, Sansoni V, et al. (2009) Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms. J Pathol 218: 360-369.
28. Elks CM, Mariappan N, Haque M, Guggilam A, Majid DS, et al. (2009) Chronic NF-kB blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am J Physiol Renal Physiol 296: F298-305.
29. Deji N, Kume S, Araki S, Soumura M, Sugimoto T, et al. (2009) Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol 296: F118-126.
30. Nakanishi K, Onuma S, Higa M, Nagai Y, Inokuchi T, (2005) The intrarenal blood flow distribution and role of nitric oxide in diabetic rats. Metabolism 54: 788-792.
31. Ghosh S, Hayden MS, (2008) New regulators of NF-kappaB in inflammation. Nat Rev Immunol 8: 837-848.
32. Henke N, Schmidt-Ullrich R, Dechend R, Park JK, Qadri F, et al. (2007) Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage. Circ Res 101: 268-276.
33. Jeon KI, Xu X, Aizawa T, Lim JH, Jono H, et al. (2010) Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proc Natl Acad Sci USA 107: 9795-9800.
34. Wu CC, Cheng J, Zhang FF, Gotlinger KH, Kelkar M, et al. (2011) Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase. Hypertension 57: 788-794.
35. Guzik TJ, Harrison DG, (2007) Endothelial NF-kappaB as a mediator of kidney damage: the missing link between systemic vascular and renal disease? Circ Res 101: 227-229.